Indian stock markets saw a dip on Friday, following global trends. Concerns over technology stock valuations and potential US interest rate hikes impacted investor sentiment. Despite a cautious mood, analysts suggest the Nifty may soon reach new highs. Foreign investors were net sellers, while domestic investors bought shares. The market awaits clarity on the US-India trade deal.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026